Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Stem Cell Therapy Market Overview for 2024 to 2034

The stem cell therapy market is expected to grow at a CAGR of 12.1% during the projected period. The market value is expected to increase from US$ 16.7 billion in 2024 to US$ 52.1 billion by 2034.

Attributes Details
Stem Cell Therapy Market Size, 2024 US$ 16.7 billion
Projected Market Size, 2034 US$ 52.1 billion
Value-based CAGR (2024 to 2034) 12.1%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Stem Cell Therapy Market Size, Analysis, and Insights

  • Rising prevalence of chronic diseases, such as cancer and diabetes, has been on the rise in recent years.
  • Stem cell therapy offers a promising solution to repair damaged tissues and organs, making it an attractive treatment option for patients suffering from chronic diseases.
  • The field of stem cell research has made significant advancements in recent years, leading to the development of new and innovative stem cell therapies.
  • These therapies have shown promising results in clinical trials, leading to increased interest and demand for stem cell therapy.
  • Governments and private organizations are investing heavily in stem cell research, leading to the development of new and innovative stem cell therapies.
  • The investment is driving the growth of the stem cell therapy market, making it more accessible to patients.
  • The regulatory environment for stem cell therapy has been favorable in recent years, making it easier for companies to develop and market stem cell therapies.
  • The regulations lead to an increase in the number of companies offering stem cell therapy services, leading to increased competition and lower prices.
  • Patients are becoming more aware of the benefits of stem cell therapy and are increasingly seeking out this treatment option.
  • The innovative treatment options driving the growth of the stem cell therapy market, making it one of the fastest-growing segments in the healthcare industry

Key Opportunities in the Stem Cell Therapy Market

  • Investments in research and development are expected to create significant opportunities during the forecast period.
  • Companies that invest heavily in research and development can also benefit from favorable regulatory environments and government funding for stem cell research.
  • The expansion of stem cell therapy services presents significant market opportunities for companies operating in the healthcare industry.
  • The market expansion is expected to help companies capture a larger profit share and attract new customers.
  • Collaborations and partnerships between companies operating in the market are likely to help them leverage each other's strengths, boosting market penetration.
  • Companies are expected to collaborate on research and development, marketing, and distribution to gain a competitive advantage.
  • The development of personalized medicine presents significant opportunities for companies operating in the stem cell therapy market.
  • Stem cell therapy can be used to develop personalized treatments for patients, generating significant growth opportunities for companies operating in the market.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Challenges in the Stem Cell Therapy Market

  • Limited understanding of the mechanisms of action of stem cell therapies, makes it difficult to predict their efficacy and the associated potential risks.
  • There is also a lack of long-term data on the safety and efficacy of stem cell therapies, which makes it challenging to evaluate their long-term effects on patients.
  • The high cost of stem cell therapies also restricts market growth. The high cost of research and development, as well as the strict regulatory requirements, have resulted in high prices for stem cell therapies.
  • The market is highly competitive, with a large number of players offering similar treatments.
  • Competition makes it difficult for new entrants to gain a foothold in the market and compete against established players.
  • Lack of awareness and understanding among patients and healthcare providers about stem cell therapies also inhibits market growth.
  • Misunderstanding among patients results in limited adoption of these treatments despite their potential to address unmet medical needs.

Comparative View of Adjacent Markets

Apart from analyzing the stem cell therapy market, a comprehensive evaluation has been carried out on two related markets, which are the cell culture incubator market and the cell regeneration medicine market.

Rapidly growing demand for biotechnological and pharmaceutical products has been fueling the cell culture incubator market, making it a pivotal component in the research and development of life-saving medications and innovative therapies.

The cell regeneration medicine market is witnessing a surge in demand owing to its potential to revolutionize modern medicine by offering a novel therapeutic approach for treating chronic diseases and injuries through the use of regenerative cells and tissues.

Stem Cell Therapy Market:

Attributes Stem Cell Therapy Market
Value-based CAGR (2024 to 2034) 12.1%
Market Trends Rising prevalence of chronic diseases, such as cancer and diabetes, has been on the rise in recent years.
Growth Opportunities Invest in research and development

Cell Culture Incubator Market:

Attributes Cell Culture Incubator Market
Value-based CAGR (2024 to 2034) 6.4%
Market Trends Increasing regulatory approvals for cell culture-based vaccines, rising chronic disease incidence, rising demand for monoclonal antibodies, funding for cell-based research, and technological advancements in cell culture incubators
Growth Opportunities increased efforts of cell culture incubator companies to bring sophisticated solutions and products to the market

Cell Regeneration Medicine Market:

Attributes Cell Regeneration Medicine Market
Value-based CAGR (2024 to 2034) 14.4%
Market Trends adoption of stem cell technology and the emergence and application of nanotechnology
Growth Opportunities widespread adoption of organ transplantation

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

In terms of Therapy, the Autologous Cellular Immunotherapies Segment Leads the Market Growth

Attributes Details
Top Therapy Autologous Cellular Immunotherapies
CAGR (2024 to 2034) 11.8%
  • Rising prevalence of chronic diseases, increasing healthcare expenditure, and growing research and development initiatives for innovative therapeutic solutions are expected to drive the segment’s growth.
  • The growing preference for non-invasive and cost-effective therapeutic options is driving the demand for autologous cellular immunotherapies, as they offer a minimally invasive alternative to traditional treatments such as chemotherapy and radiation therapy.
  • Increasing number of clinical trials and collaborations between research institutes and pharmaceutical companies
  • Developing innovative stem cell therapies is propelling the growth of autologous cellular immunotherapies.

In terms of Source, the Bone Marrow Segment is dominating the Market

Attributes Details
Top Source Bone Marrow
CAGR (2024 to 2034) 11.6%
  • Widespread availability, proven clinical efficacy, and versatile applications in the treatment of a variety of medical conditions such as blood disorders, immune system disorders, and certain types of cancer.
  • Increasing prevalence of blood disorders such as leukemia, lymphoma, and sickle cell anemia is driving the demand for bone marrow stem cell therapy.
  • Growing number of successful bone marrow transplants and the increasing adoption of stem cell therapies in clinical practice is further fueling the growth of the bone marrow segment.

Country-wise insights

Countries CAGR through 2034
United States 12.3%
United Kingdom 13.3%
China 12.8%
Japan 13.7%
South Korea 14.0%

Presence of Advanced Healthcare Infrastructure in the United States

  • Rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, and the growing need for innovative therapeutic solutions in the United States.
  • Increasing healthcare expenditure, a growing geriatric population, and favorable reimbursement policies are also driving the demand for stem cell therapy in the country.
  • The United States is home to several leading pharmaceutical and biotech companies that are investing heavily in research and development initiatives for developing innovative stem cell therapies.
  • The presence of advanced healthcare infrastructure and a well-established regulatory framework for stem cell therapy is also propelling the growth of the market in the country.
  • Increasing number of clinical trials and collaborations between research institutes and pharmaceutical companies aimed at exploring the therapeutic potential of stem cells for a range of medical conditions is further boosting the demand for stem cell therapy in the United States.

Increasing Number of Stem Cell Research Initiatives and Clinical Trials in the United Kingdom

  • Favourable regulatory environment for stem cell therapy, robust healthcare infrastructure, and increasing collaborations between academia and the industry are driving the growth of the market in the United Kingdom.
  • The United Kingdom has a well-established National Health Service (NHS) that provides universal access to healthcare, including stem cell therapy, to its citizens.
  • Increasing number of stem cell research initiatives and clinical trials aimed at developing innovative therapeutic solutions for medical conditions such as cancer, heart disease, and neurological disorders are also contributing to the growth of the market in the United Kingdom.
  • The availability of advanced technologies for the isolation, purification, and expansion of stem cells, as well as the increasing adoption of stem cell therapy in clinical practice, is further propelling the growth of the market in the country.

Availability of Cost-Effective and High-Quality Treatment Options in China

  • The large population of the country, particularly the aging population, is driving the demand for stem cell therapies.
  • China has emerged as a leading destination for stem cell therapy owing to the availability of cost-effective and high-quality treatment options, as well as the presence of advanced healthcare infrastructure and a well-established regulatory framework for stem cell therapy.
  • The Chinese government has been actively promoting the development of stem cell therapy by providing funding support and favorable regulations to researchers and pharmaceutical companies.
  • The stem cell therapy market in China is expected to witness significant growth over the coming years, transforming the country’s healthcare landscape.

Japanese Government has Been Actively Promoting the Development of Stem Cell Therapy

  • Japan has been at the forefront of stem cell research and development, with several leading pharmaceutical and biotech companies investing heavily in the development of innovative stem cell therapies.
  • The Japanese government has been actively promoting the development of stem cell therapy by providing funding support and favorable regulations to researchers and pharmaceutical companies.
  • The availability of advanced technologies for the isolation, purification, and expansion of stem cells, as well as the increasing adoption of stem cell therapy in clinical practice, is further propelling the growth of the market in Japan.

South Korea Has a Strong Reputation for Medical Tourism

  • Availability of cost-effective and high-quality treatment options, as well as the presence of advanced healthcare infrastructure and a well-established regulatory framework for stem cell therapy in South Korea.
  • South Korea has a strong reputation for medical tourism, with patients from around the world seeking cost-effective and high-quality stem cell therapy options, fueling the growth of the market.

Competitive Landscape

The market is highly competitive due to the presence of several leading pharmaceutical and biotech companies. It is characterized by intense competition, rapid technological advancements, and a high degree of research and development activities aimed at developing innovative stem cell therapies. Companies are investing heavily in research and development initiatives aimed at developing novel stem cell therapies for a range of medical conditions.

Recent Development in the Stem Cell Therapy Market

In 2020, Cipla and Stempeutics formed a strategic collaboration to introduce Stempucel, a groundbreaking stem cell therapy for the treatment of critical limb ischemia. The collaboration is aimed at capitalizing on the growing demand for stem cell therapies and expanding their market share in this rapidly evolving field. The launch of Stempucel is expected to revolutionize the treatment of critical limb ischemia, a debilitating condition that affects millions of people worldwide.

Key Market Players

  • Mesoblast Ltd.
  • Celgene Corporation
  • Athersys, Inc.
  • Osiris Therapeutics, Inc.
  • Pluristem Therapeutics, Inc.
  • Vericel Corporation
  • NuVasive, Inc.
  • BrainStorm Cell Therapeutics, Inc.
  • Takeda Pharmaceutical Company Limited
  • Cynata Therapeutics Limited
  • ReNeuron Group plc
  • Regeneus Ltd.
  • StemCells Inc.
  • Cytori Therapeutics, Inc.
  • Pharmicell Co., Ltd.

Key Coverage in the Stem Cell Therapy Market Report

  • Cell-Based Therapy Market Report
  • Embryonic Stem Cell Therapy Industry Analysis
  • Stem Cell Therapy Sales Assessment
  • Stem Cell Transplant Market Overview
  • Allogeneic Stem Cell Therapy Pricing Outlook

Key Market Segmentation

By Therapy:

  • Autologous Cellular Immunotherapies
  • Autologous Stem Cell Therapy

By Source:

  • Bone Marrow
  • Epidermis
  • Mesenchymal Stem Cells
  • Other sources

By Application:

  • Cancer
  • Cardiovascular Disorders
  • Neurodegenerative Disorders
  • Orthopedics
  • Other Applications

By End Use:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Research Centers
  • Other End-Users

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia
  • Europe
  • Oceania
  • MEA

Frequently Asked Questions

How Big is the Stem Cell Therapy Market in 2024?

The market is estimated to be valued at US$ 16.7 billion in 2024.

What is China’s Market Outlook?

The market in China is expected to progress at a CAGR of 12.8% through the forecast period.

Which Device Segment Contributes More to the Stem Cell Therapy Market?

Within the therapy, the autologous cellular immunotherapies segment is expected to register an 11.8% CAGR from 2024 to 2034

What is the United States Market Outlook?

The United States market is expected to rise at a 12.3% CAGR from 2024 to 2034.

What is the Projected Market Value by 2034?

The market is set to reach a valuation of US$ 52.1 billion by 2034.

What was the Historical CAGR for the Market?

The demand for stem cell therapies increased at a 15.6% CAGR from 2019 to 2023.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

    4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Therapy, 2019 to 2023

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Therapy, 2024 to 2034

        5.3.1. Autologous Cellular Immunotherapies

        5.3.2. Autologous Stem Cell Therapy

    5.4. Y-o-Y Growth Trend Analysis By Therapy, 2019 to 2023

    5.5. Absolute $ Opportunity Analysis By Therapy, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Source

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Source, 2019 to 2023

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Source, 2024 to 2034

        6.3.1. Bone Marrow

        6.3.2. Epidermis

        6.3.3. Mesenchymal Stem Cells

        6.3.4. Other Sources

    6.4. Y-o-Y Growth Trend Analysis By Source, 2019 to 2023

    6.5. Absolute $ Opportunity Analysis By Source, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034

        7.3.1. Cancer

        7.3.2. Cardiovascular Disorders

        7.3.3. Neurodegenerative Disorders

        7.3.4. Orthopedics

        7.3.5. Other Applications

    7.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023

    7.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-Use

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By End-Use, 2019 to 2023

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-Use, 2024 to 2034

        8.3.1. Hospitals & Clinics

        8.3.2. Ambulatory Surgical Centers

        8.3.3. Research Centers

        8.3.4. Other End-Users

    8.4. Y-o-Y Growth Trend Analysis By End-Use, 2019 to 2023

    8.5. Absolute $ Opportunity Analysis By End-Use, 2024 to 2034

9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023

    9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Western Europe

        9.3.4. Eastern Europe

        9.3.5. South Asia and Pacific

        9.3.6. East Asia

        9.3.7. Middle East and Africa

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        10.2.1. By Country

            10.2.1.1. USA

            10.2.1.2. Canada

        10.2.2. By Therapy

        10.2.3. By Source

        10.2.4. By Application

        10.2.5. By End-Use

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Therapy

        10.3.3. By Source

        10.3.4. By Application

        10.3.5. By End-Use

    10.4. Key Takeaways

11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Therapy

        11.2.3. By Source

        11.2.4. By Application

        11.2.5. By End-Use

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Therapy

        11.3.3. By Source

        11.3.4. By Application

        11.3.5. By End-Use

    11.4. Key Takeaways

12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. UK

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Western Europe

        12.2.2. By Therapy

        12.2.3. By Source

        12.2.4. By Application

        12.2.5. By End-Use

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Therapy

        12.3.3. By Source

        12.3.4. By Application

        12.3.5. By End-Use

    12.4. Key Takeaways

13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        13.2.1. By Country

            13.2.1.1. Poland

            13.2.1.2. Russia

            13.2.1.3. Czech Republic

            13.2.1.4. Romania

            13.2.1.5. Rest of Eastern Europe

        13.2.2. By Therapy

        13.2.3. By Source

        13.2.4. By Application

        13.2.5. By End-Use

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Therapy

        13.3.3. By Source

        13.3.4. By Application

        13.3.5. By End-Use

    13.4. Key Takeaways

14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        14.2.1. By Country

            14.2.1.1. India

            14.2.1.2. Bangladesh

            14.2.1.3. Australia

            14.2.1.4. New Zealand

            14.2.1.5. Rest of South Asia and Pacific

        14.2.2. By Therapy

        14.2.3. By Source

        14.2.4. By Application

        14.2.5. By End-Use

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Therapy

        14.3.3. By Source

        14.3.4. By Application

        14.3.5. By End-Use

    14.4. Key Takeaways

15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        15.2.1. By Country

            15.2.1.1. China

            15.2.1.2. Japan

            15.2.1.3. South Korea

        15.2.2. By Therapy

        15.2.3. By Source

        15.2.4. By Application

        15.2.5. By End-Use

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Therapy

        15.3.3. By Source

        15.3.4. By Application

        15.3.5. By End-Use

    15.4. Key Takeaways

16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        16.2.1. By Country

            16.2.1.1. GCC Countries

            16.2.1.2. South Africa

            16.2.1.3. Israel

            16.2.1.4. Rest of MEA

        16.2.2. By Therapy

        16.2.3. By Source

        16.2.4. By Application

        16.2.5. By End-Use

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Therapy

        16.3.3. By Source

        16.3.4. By Application

        16.3.5. By End-Use

    16.4. Key Takeaways

17. Key Countries Market Analysis

    17.1. USA

        17.1.1. Market Share Analysis, 2023

            17.1.1.1. By Therapy

            17.1.1.2. By Source

            17.1.1.3. By Application

            17.1.1.4. By End-Use

    17.2. Canada

        17.2.1. Market Share Analysis, 2023

            17.2.1.1. By Therapy

            17.2.1.2. By Source

            17.2.1.3. By Application

            17.2.1.4. By End-Use

    17.3. Brazil

        17.3.1. Market Share Analysis, 2023

            17.3.1.1. By Therapy

            17.3.1.2. By Source

            17.3.1.3. By Application

            17.3.1.4. By End-Use

    17.4. Mexico

        17.4.1. Market Share Analysis, 2023

            17.4.1.1. By Therapy

            17.4.1.2. By Source

            17.4.1.3. By Application

            17.4.1.4. By End-Use

    17.5. Germany

        17.5.1. Market Share Analysis, 2023

            17.5.1.1. By Therapy

            17.5.1.2. By Source

            17.5.1.3. By Application

            17.5.1.4. By End-Use

    17.6. UK

        17.6.1. Market Share Analysis, 2023

            17.6.1.1. By Therapy

            17.6.1.2. By Source

            17.6.1.3. By Application

            17.6.1.4. By End-Use

    17.7. France

        17.7.1. Market Share Analysis, 2023

            17.7.1.1. By Therapy

            17.7.1.2. By Source

            17.7.1.3. By Application

            17.7.1.4. By End-Use

    17.8. Spain

        17.8.1. Market Share Analysis, 2023

            17.8.1.1. By Therapy

            17.8.1.2. By Source

            17.8.1.3. By Application

            17.8.1.4. By End-Use

    17.9. Italy

        17.9.1. Market Share Analysis, 2023

            17.9.1.1. By Therapy

            17.9.1.2. By Source

            17.9.1.3. By Application

            17.9.1.4. By End-Use

    17.10. Poland

        17.10.1. Market Share Analysis, 2023

            17.10.1.1. By Therapy

            17.10.1.2. By Source

            17.10.1.3. By Application

            17.10.1.4. By End-Use

    17.11. Russia

        17.11.1. Market Share Analysis, 2023

            17.11.1.1. By Therapy

            17.11.1.2. By Source

            17.11.1.3. By Application

            17.11.1.4. By End-Use

    17.12. Czech Republic

        17.12.1. Market Share Analysis, 2023

            17.12.1.1. By Therapy

            17.12.1.2. By Source

            17.12.1.3. By Application

            17.12.1.4. By End-Use

    17.13. Romania

        17.13.1. Market Share Analysis, 2023

            17.13.1.1. By Therapy

            17.13.1.2. By Source

            17.13.1.3. By Application

            17.13.1.4. By End-Use

    17.14. India

        17.14.1. Market Share Analysis, 2023

            17.14.1.1. By Therapy

            17.14.1.2. By Source

            17.14.1.3. By Application

            17.14.1.4. By End-Use

    17.15. Bangladesh

        17.15.1. Market Share Analysis, 2023

            17.15.1.1. By Therapy

            17.15.1.2. By Source

            17.15.1.3. By Application

            17.15.1.4. By End-Use

    17.16. Australia

        17.16.1. Market Share Analysis, 2023

            17.16.1.1. By Therapy

            17.16.1.2. By Source

            17.16.1.3. By Application

            17.16.1.4. By End-Use

    17.17. New Zealand

        17.17.1. Market Share Analysis, 2023

            17.17.1.1. By Therapy

            17.17.1.2. By Source

            17.17.1.3. By Application

            17.17.1.4. By End-Use

    17.18. China

        17.18.1. Market Share Analysis, 2023

            17.18.1.1. By Therapy

            17.18.1.2. By Source

            17.18.1.3. By Application

            17.18.1.4. By End-Use

    17.19. Japan

        17.19.1. Market Share Analysis, 2023

            17.19.1.1. By Therapy

            17.19.1.2. By Source

            17.19.1.3. By Application

            17.19.1.4. By End-Use

    17.20. South Korea

        17.20.1. Market Share Analysis, 2023

            17.20.1.1. By Therapy

            17.20.1.2. By Source

            17.20.1.3. By Application

            17.20.1.4. By End-Use

    17.21. GCC Countries

        17.21.1. Market Share Analysis, 2023

            17.21.1.1. By Therapy

            17.21.1.2. By Source

            17.21.1.3. By Application

            17.21.1.4. By End-Use

    17.22. South Africa

        17.22.1. Market Share Analysis, 2023

            17.22.1.1. By Therapy

            17.22.1.2. By Source

            17.22.1.3. By Application

            17.22.1.4. By End-Use

    17.23. Israel

        17.23.1. Market Share Analysis, 2023

            17.23.1.1. By Therapy

            17.23.1.2. By Source

            17.23.1.3. By Application

            17.23.1.4. By End-Use

18. Market Structure Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Market Share Analysis of Top Players

        18.3.1. By Regional

        18.3.2. By Therapy

        18.3.3. By Source

        18.3.4. By Application

        18.3.5. By End-Use

19. Competition Analysis

    19.1. Competition Deep Dive

        19.1.1. Lonza Group AG

            19.1.1.1. Overview

            19.1.1.2. Product Portfolio

            19.1.1.3. Profitability by Market Segments

            19.1.1.4. Sales Footprint

            19.1.1.5. Strategy Overview

                19.1.1.5.1. Marketing Strategy

        19.1.2. Novartis AG

            19.1.2.1. Overview

            19.1.2.2. Product Portfolio

            19.1.2.3. Profitability by Market Segments

            19.1.2.4. Sales Footprint

            19.1.2.5. Strategy Overview

                19.1.2.5.1. Marketing Strategy

        19.1.3. Bristol-Myers Squibb Company

            19.1.3.1. Overview

            19.1.3.2. Product Portfolio

            19.1.3.3. Profitability by Market Segments

            19.1.3.4. Sales Footprint

            19.1.3.5. Strategy Overview

                19.1.3.5.1. Marketing Strategy

        19.1.4. Corning Incorporated

            19.1.4.1. Overview

            19.1.4.2. Product Portfolio

            19.1.4.3. Profitability by Market Segments

            19.1.4.4. Sales Footprint

            19.1.4.5. Strategy Overview

                19.1.4.5.1. Marketing Strategy

        19.1.5. Holostem Terapie Avanzate S.r.l.

            19.1.5.1. Overview

            19.1.5.2. Product Portfolio

            19.1.5.3. Profitability by Market Segments

            19.1.5.4. Sales Footprint

            19.1.5.5. Strategy Overview

                19.1.5.5.1. Marketing Strategy

        19.1.6. CORESTEM, Inc

            19.1.6.1. Overview

            19.1.6.2. Product Portfolio

            19.1.6.3. Profitability by Market Segments

            19.1.6.4. Sales Footprint

            19.1.6.5. Strategy Overview

                19.1.6.5.1. Marketing Strategy

        19.1.7. Sanpower Group

            19.1.7.1. Overview

            19.1.7.2. Product Portfolio

            19.1.7.3. Profitability by Market Segments

            19.1.7.4. Sales Footprint

            19.1.7.5. Strategy Overview

                19.1.7.5.1. Marketing Strategy

        19.1.8. Tego Science

            19.1.8.1. Overview

            19.1.8.2. Product Portfolio

            19.1.8.3. Profitability by Market Segments

            19.1.8.4. Sales Footprint

            19.1.8.5. Strategy Overview

                19.1.8.5.1. Marketing Strategy

        19.1.9. Gilead Sciences

            19.1.9.1. Overview

            19.1.9.2. Product Portfolio

            19.1.9.3. Profitability by Market Segments

            19.1.9.4. Sales Footprint

            19.1.9.5. Strategy Overview

                19.1.9.5.1. Marketing Strategy

        19.1.10. Vericel Corporation

            19.1.10.1. Overview

            19.1.10.2. Product Portfolio

            19.1.10.3. Profitability by Market Segments

            19.1.10.4. Sales Footprint

            19.1.10.5. Strategy Overview

                19.1.10.5.1. Marketing Strategy

20. Assumptions & Acronyms Used

21. Research Methodology

Recommendations

Healthcare

Cell Culture Incubator Market

Published : July 2023

Healthcare

Cell Regeneration Medicine Market

Published : October 2022

Explore Healthcare Insights

View Reports